Printed From:

Dosing1

CHOOSE THE RIGHT STARTING DOSE FOR EACH ADULT T2DM PATIENT

THEN TITRATE BY 2-4 UNITS WEEKLY

  • The maximum dose of 60 Units is available only in the SOLIQUA 100/33 SoloStar® pen
  • SOLIQUA 100/33 is delivered subcutaneously, via the SOLIQUA 100/33 SoloStar® pen, once daily within one hour prior to the first meal of the day
  • Use alternative treatments if doses below 15 Units or above 60 Units are required

*Starting dose is based on current dose of basal insulin.

One Unit of SOLIQUA 100/33 contains 1 Unit of Lantus® and 0.33 mcg of lixisenatide.

15 Units is the recommended starting dose for patients uncontrolled on lixisenatide, a GLP-1 receptor agonist.

  • SOLIQUA 100/33 is to be dosed based on the patient’s metabolic needs, blood glucose monitoring results, and glycemic goals
  • The dose on the SOLIQUA 100/33 SoloStar ® pen can be adjusted in 1-Unit increments

ONCE-DAILY ADMINISTRATION

Within one hour prior to first meal of the day

ONE CO-PAY FOR 2 MEDICINES
THE PEN TECHNOLOGY YOUR OFFICE STAFF AND LANTUS ® PATIENTS WILL FIND FAMILIAR